Intensive Lifestyle Intervention Fails to Improve Patient-Oriented Outcomes in Persons with Obesity and Diabetes
FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.
FREE PREVIEW. Purchase online access to read the full version of this article.
Am Fam Physician. 2013 Dec 15;88(12):online.
Does an intensive lifestyle intervention focused on weight loss and exercise improve outcomes in patients with diabetes mellitus?
This large, well-designed trial failed to find a statistically significant improvement in patient-oriented outcomes in patients with diabetes, despite a fairly intensive lifestyle intervention and long-term follow-up. (Level of Evidence = 1b)
There is relatively little high-quality clinical trial evidence to support recommendations for weight loss and exercise in patients with type 2 diabetes. In this study, 5,145 adults, 45 to 75 years of age, with type 2 diabetes and a body mass index of at least 25 kg per m2 were randomized to receive an intensive lifestyle intervention (weekly visits providing group and individual counseling regarding calorie-reducing diet and exercise, with a goal of 7% weight loss and at least 175 minutes of exercise per week), or support and education (three group sessions per year in years 1 to 4, and one session per year after that). At the beginning of the study, all participants had an A1C level of 11% or less, blood pressure lower than 160/100 mm Hg, a triglyceride level less than 600 mg per dL (6.77 mmol per L), an established relationship with their primary care physician, and clearance to exercise. The mean age of participants was 59 years, 40% were men, and 37% were of a nonwhite race or ethnicity. Their average body mass index was 36 kg per m2, and the average weight was 101 kg (222 lb). Groups were balanced at the start of the study, outcomes were adjudicated by persons masked to group assignment (patients and their physicians were not masked), and patients were followed for a median of 9.6 years.
At one year, patients in the intervention group had greater weight loss (about 8 kg [18 lb]), greater reduction in waist circumference (7 cm [2.8 in]), greater reduction in A1C level (0.6%), and an increase in fitness level (as measured in metabolic units). These differences diminished over time as the control group gradually showed improvement in these parameters and the intervention group showed evidence of backsliding. There were no differences in key clinical outcomes, including all-cause mortality (0.73% intervention vs. 0.86% control) and a composite primary outcome of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina (1.83% intervention vs. 1.92% control). Most of the individual outcomes had relative risks of less than 1.0, but none were statistically significant. The study was adequately powered to detect an 18% relative reduction in the primary outcome if one existed. Patients in the intervention group did have lower rates of statin, antihypertensive, and insulin use at the end of the study than those in the control group.
Study design: Randomized controlled trial (single-blinded)
Funding source: Government
Reference: Wing RR, Bolin P, Brancati FL, et al.; Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med.. 2013; 369( 2): 145– 154.
POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Sep 15, 2016
Access the latest issue of American Family Physician